234 related articles for article (PubMed ID: 23228009)
1. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
Levin BE; Katzen HL; Maudsley A; Post J; Myerson C; Govind V; Nahab F; Scanlon B; Mittel A
J Neuroimaging; 2014; 24(1):39-44. PubMed ID: 23228009
[TBL] [Abstract][Full Text] [Related]
2. Replicability of proton MR spectroscopic imaging findings in mild traumatic brain injury: Implications for clinical applications.
Chen AM; Gerhalter T; Dehkharghani S; Peralta R; Gajdošík M; Gajdošík M; Tordjman M; Zabludovsky J; Sheriff S; Ahn S; Babb JS; Bushnik T; Zarate A; Silver JM; Im BS; Wall SP; Madelin G; Kirov II
Neuroimage Clin; 2023; 37():103325. PubMed ID: 36724732
[TBL] [Abstract][Full Text] [Related]
3. Detection and application of neurochemical profile by multiple regional
Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
[TBL] [Abstract][Full Text] [Related]
4. Physiological neuronal decline in healthy aging human brain - An in vivo study with MRI and short echo-time whole-brain (1)H MR spectroscopic imaging.
Ding XQ; Maudsley AA; Sabati M; Sheriff S; Schmitz B; Schütze M; Bronzlik P; Kahl KG; Lanfermann H
Neuroimage; 2016 Aug; 137():45-51. PubMed ID: 27164326
[TBL] [Abstract][Full Text] [Related]
5. Whole-brain proton MR spectroscopic imaging of mild-to-moderate traumatic brain injury and correlation with neuropsychological deficits.
Govind V; Gold S; Kaliannan K; Saigal G; Falcone S; Arheart KL; Harris L; Jagid J; Maudsley AA
J Neurotrauma; 2010 Mar; 27(3):483-96. PubMed ID: 20201668
[TBL] [Abstract][Full Text] [Related]
6. Proton spectroscopic imaging of brain metabolites in basal ganglia of healthy older adults.
Parikh J; Thrippleton MJ; Murray C; Armitage PA; Harris BA; Andrews PJ; Wardlaw JM; Starr JM; Deary IJ; Marshall I
MAGMA; 2015 Jun; 28(3):251-7. PubMed ID: 25312604
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.
Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C
J Neuroimaging; 2015; 25(1):105-10. PubMed ID: 24325203
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.
Govind V; Sharma KR; Maudsley AA; Arheart KL; Saigal G; Sheriff S
PLoS One; 2012; 7(4):e35607. PubMed ID: 22539984
[TBL] [Abstract][Full Text] [Related]
9. Proton MR spectroscopic imaging of the striatum in Parkinson's disease.
Cruz CJ; Aminoff MJ; Meyerhoff DJ; Graham SH; Weiner MW
Magn Reson Imaging; 1997; 15(6):619-24. PubMed ID: 9285801
[TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.
Baik HM; Choe BY; Son BC; Jeun SS; Kim MC; Lee KS; Kim BS; Lee JM; Lee HK; Suh TS
Eur J Radiol; 2003 Sep; 47(3):179-87. PubMed ID: 12927660
[TBL] [Abstract][Full Text] [Related]
11. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus.
Brooks WM; Jung RE; Ford CC; Greinel EJ; Sibbitt WL
J Rheumatol; 1999 Jan; 26(1):81-5. PubMed ID: 9918245
[TBL] [Abstract][Full Text] [Related]
12. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.
Angelie E; Bonmartin A; Boudraa A; Gonnaud PM; Mallet JJ; Sappey-Marinier D
AJNR Am J Neuroradiol; 2001 Jan; 22(1):119-27. PubMed ID: 11158897
[TBL] [Abstract][Full Text] [Related]
13. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.
Nie K; Zhang Y; Huang B; Wang L; Zhao J; Huang Z; Gan R; Wang L
Parkinsonism Relat Disord; 2013 Mar; 19(3):329-34. PubMed ID: 23238068
[TBL] [Abstract][Full Text] [Related]
14. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
16. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
Fountas KN; Tsougos I; Gotsis ED; Giannakodimos S; Smith JR; Kapsalaki EZ
Neurosurg Focus; 2012 Mar; 32(3):E3. PubMed ID: 22380857
[TBL] [Abstract][Full Text] [Related]
17. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
18. Fast mapping of the T2 relaxation time of cerebral metabolites using proton echo-planar spectroscopic imaging (PEPSI).
Tsai SY; Posse S; Lin YR; Ko CW; Otazo R; Chung HW; Lin FH
Magn Reson Med; 2007 May; 57(5):859-65. PubMed ID: 17457864
[TBL] [Abstract][Full Text] [Related]
19. Computation of brain metabolite ratios in single-voxel proton MR spectroscopy: comparison between semiautomatic and automatic software.
Mazzoni LN; Belli G; Ginestroni A; Pratesi A; Agnoloni S; Diciotti S; Mascalchi M
Radiol Med; 2010 Feb; 115(1):125-32. PubMed ID: 19562268
[TBL] [Abstract][Full Text] [Related]
20. Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment.
Chaudhary S; Kumaran SS; Goyal V; Kalaivani M; Kaloiya GS; Sagar R; Mehta N; Srivastava AK; Jagannathan NR
Neurol Sci; 2021 Mar; 42(3):1053-1064. PubMed ID: 32729012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
